BioSpace News Archive

Business

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

Agreement Leverages Prometheus Biosciences’ Proprietary Bioinformatics Analysis Platform, Companion Diagnostics to Speed Development and Discovery

October 3, 2019
·
2 min read
Medicure Announces Preferred Pricing Agreement for Zypitamag™ with the AIDS Drug Assistance Program (“ADAP”) Crisis Task Force

Medicure Inc. is pleased to announce that it has reached a preferred pricing agreement with the AIDS Drug Assistance Program Crisis Task Force for ZYPITAMAGTM tablets.

October 3, 2019
·
10 min read
Business

Rafael Holdings Reports Fourth Quarter and Full Fiscal Year 2019 Results

Rafael Holdings, Inc.,, reported revenue of $4.9 million and a loss per share of $0.35 for the fiscal year ended July 31, 2019.

October 3, 2019
·
2 min read
Deals

Heron Therapeutics Announces Pricing of Public Offering of Common Stock - Oct. 3, 2019

Heron Therapeutics, Inc. announced the pricing of an underwritten public offering of 8,571,429 shares of its common stock at a price of $17.50 per share.

October 3, 2019
·
4 min read
Drug Development

New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions in Total Symptom Score, Mucus Weight and RSV Viral Load

Enanta plans to initiate a Phase 2b clinical study of EDP-938 in adult out-patients with RSV by the end of 2019.

October 3, 2019
·
6 min read
Job Trends

Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor’s Choice

Article Reviewing Rapid Acoustic Pulse Technology to be included in next “Lasers in Surgery and Medicine” Journal

October 3, 2019
·
3 min read
Genetown

Blue Cross Blue Shield Of Massachusetts Adds Acupuncture Coverage

State’s largest health plan adds benefit to increase options for non-opioid pain relief

October 3, 2019
·
3 min read
Perrigo Announces the Relaunch of the AB Rated Generic Version of Transderm Scop® 1.5 MG

Perrigo Company plc announced the relaunch of the AB rated generic equivalent of Transderm Scop®.

October 3, 2019
·
4 min read
Drug Development

Oncternal Therapeutics Announces Opening of Phase 1b Expansion Cohort of Clinical Trial of Cirmtuzumab in Combination with Ibrutinib in Patients with Mantle Cell Lymphoma

Cirmtuzumab combination demonstrated clinical activity with complete responses in mantle cell lymphoma

October 3, 2019
·
8 min read
Biotech Beach

Inscopix Showcases New Products and Key Scientific Presentations at the 49th Annual Meeting of the Society for Neuroscience

Inscopix researchers to deliver oral presentation describing first use of technology in rhesus macaque

October 3, 2019
·
4 min read